SCHEMBL31347336

SCHEMBL31347336

NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(N)=O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 4/20 0.42
▸ OPRM1 P35372 4/20 0.38
▸ OPRD1 P41143 4/20 0.38
▸ APLNR P35414 1/20 0.38
▸ NMT2 O60551 1/20 0.38
▸ NMT1 P30419 1/20 0.38
▸ PSMB9 P28065 2/20 0.37
▸ CTSB P07858 1/20 0.37
▸ NAA50 Q9GZZ1 1/20 0.37
▸ DPP4 P27487 1/20 0.36
▸ PREP P48147 1/20 0.36
▸ FAP Q12884 1/20 0.36
▸ TBXA2R P21731 1/20 0.36
▸ AVPR1A P37288 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ PDE3A Q14432 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29763113 0.92 CAPN1 (0.41) CAPN1OPRM1OPRD1APLNRNMT2
SCHEMBL30138993 0.89 OPRM1 (0.42) CAPN1OPRM1OPRD1NMT2NMT1
SCHEMBL31751644 0.86 OPRM1 (0.43) CAPN1OPRM1OPRD1APLNRPSMB9
SCHEMBL29679564 0.85 OPRM1 (0.42) CAPN1OPRM1OPRD1PSMB9PREP
SCHEMBL30028652 0.85 ITGB1 (0.43) CAPN1OPRM1OPRD1CTSBPREP
SCHEMBL30138992 0.84 CAPN1 (0.40) CAPN1OPRM1OPRD1PSMB9DPP4
SCHEMBL31751216 0.83 OPRM1 (0.43) CAPN1OPRM1OPRD1APLNRPSMB9
SCHEMBL29691750 0.82 CAPN1 (0.54) CAPN1OPRM1OPRD1APLNRCTSB
SCHEMBL30918789 0.82 OPRM1 (0.46) OPRM1OPRD1APLNRNMT2NMT1
SCHEMBL29760955 0.82 OPRM1 (0.41) CAPN1OPRM1OPRD1PSMB9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724472-A2 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 — — EP claimed
WO-2024252367-A2 NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2024-12-12 — — WO claimed
EP-4724472-A2 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 — — EP disclosed
WO-2024252367-A2 NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2024-12-12 — — WO disclosed
Send feedback